Related Experiment Videos

Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes

Insights

Patients with Hodgkin

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Hodgkin's disease (HD) is a cancer of the lymphatic system.
  • Lymphocyte cyclic nucleotide levels are altered in HD patients.
  • Cyclic nucleotide phosphodiesterase (PDE) enzymes regulate cyclic nucleotide levels.

Purpose of the Study:

  • To investigate cyclic nucleotide phosphodiesterase (PDE) activities in lymphocytes from Hodgkin's disease patients.
  • To determine if altered PDE activity contributes to abnormal cyclic nucleotide levels in HD.

Main Methods:

  • Studied PDE activities in peripheral blood monocyte-depleted lymphocytes and T-lymphocyte suspensions.
  • Compared enzyme activities between thirteen untreated HD patients and fourteen healthy volunteers.
  • Assessed PDE activity in the presence and absence of calmodulin and calcium.

Main Results:

  • Monocyte-depleted lymphocytes from HD patients exhibited twofold higher PDE activities than controls.
  • T-lymphocyte suspensions from HD patients showed fourfold higher cAMP-PDE and threefold higher cGMP-PDE activities.
  • PDE hydrolytic activities were unaffected by calmodulin and calcium in both groups.

Conclusions:

  • Elevated PDE activities in lymphocytes may be responsible for altered cyclic nucleotide levels in Hodgkin's disease.
  • These findings highlight the role of PDE dysregulation in the immunodeficiency associated with HD.

Related Concept Videos